SabiDoc ("we", "us") provides a telehealth marketplace connecting patients in Ghana with licensed doctors, therapists, and specialists. SabiDoc is a subsidiary of Onyina Infrastructure Holdings. This policy explains what personal data we collect, why, and the rights you have over it under Ghana's Data Protection Act, 2012 (Act 843).
Under Act 843, information about your health is a special category of personal data. We treat it accordingly: it is collected only for the purpose of providing care, accessed only by the provider you consult (and, where you choose to route a prescription, the pharmacy fulfilling it), and is never sold or used for advertising.
To match you with an appropriate, verified provider; to let that provider review your history and prepare for your visit; to generate a prescription any pharmacy can verify; to process payment; and to maintain your portable health record across visits. Wellness tips shown in the app are the same generic content for every patient — we do not use your health record to personalize non-clinical content without a deliberate, separate decision to do so.
The provider you're matched with sees your intake, pre-screen answers, and history relevant to that visit. A pharmacy you route a prescription to sees only that prescription. SabiDoc staff can access records only as needed to operate the platform (for example, reviewing a complaint) or where required by law.
Under Act 843 you can ask to access, correct, or request deletion of your personal data, and object to specific processing. Contact us using the details below to exercise any of these rights.
We keep consultation records for as long as your account is active, so your record stays portable across visits and providers, and for a limited period afterward as required for legal, medical-record, or dispute-resolution purposes.
Questions about this policy or your data can be sent to privacy@sabidoc.com.
This policy will be updated as SabiDoc approaches launch and as data-handling details (retention periods, sub-processors, cross-border transfer safeguards) are finalized.
